Clinical Trial Update: Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for assessment of anti-SARS-CoV-2 serum for early treatment of COVID-19 in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Immunosuppression

Drugs mentioned

• Anti-SARS-CoV-2 serum

Snippet

Sponsor: Butantan Institute | Conditions: Immunosuppression, Cancer | Phase 1, Phase 2 | Status: UNKNOWN